Joint statement: Supply allocations of intravenous tocilizumab (Actemra) during serious shortage
Published
Related content
- Limited Ozempic supplies to commence distribution in AustraliaSupplies of Ozempic (semaglutide) have begun distribution in Australia but will remain quite limited for some time.
- TGA Provisional Approval of Roche Products Pty Ltd COVID-19 treatment, tocilizumab (ACTEMRA)On 1 December 2021, the TGA granted provisional approval to Roche Products Pty Ltd for the use of tocilizumab (ACTEMRA) for the treatment of COVID-19.
- Critical medicines supply modelling supports return to elective surgeryNew modelling demonstrates that supply of critical medicines for ventilating patients supports a return to elective surgery